191 related articles for article (PubMed ID: 7984285)
1. Slow wave sleep in humans: role of 5-HT2A and 5-HT2C receptors.
Sharpley AL; Elliott JM; Attenburrow MJ; Cowen PJ
Neuropharmacology; 1994; 33(3-4):467-71. PubMed ID: 7984285
[TBL] [Abstract][Full Text] [Related]
2. Subchronic effects of the GABA-agonist lorazepam and the 5-HT2A/2C antagonist ritanserin on driving performance, slow wave sleep and daytime sleepiness in healthy volunteers.
van Laar M; Volkerts E; Verbaten M
Psychopharmacology (Berl); 2001 Mar; 154(2):189-97. PubMed ID: 11314681
[TBL] [Abstract][Full Text] [Related]
3. Role of 5-HT1B, 5-HT2A and 5-HT2C receptors in learning.
Meneses A; Hong E
Behav Brain Res; 1997 Aug; 87(1):105-10. PubMed ID: 9331478
[TBL] [Abstract][Full Text] [Related]
4. Development of homogeneous high-affinity agonist binding assays for 5-HT2 receptor subtypes.
Song J; Hanniford D; Doucette C; Graham E; Poole MF; Ting A; Sherf B; Harrington J; Brunden K; Stricker-Krongrad A
Assay Drug Dev Technol; 2005 Dec; 3(6):649-59. PubMed ID: 16438660
[TBL] [Abstract][Full Text] [Related]
5. Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task.
Koskinen T; Ruotsalainen S; Puumala T; Lappalainen R; Koivisto E; Männistö PT; Sirviö J
Neuropharmacology; 2000 Jan; 39(3):471-81. PubMed ID: 10698013
[TBL] [Abstract][Full Text] [Related]
6. 5-HT2 receptor regulation of acetylcholine release induced by dopaminergic stimulation in rat striatal slices.
Ramírez MJ; Cenarruzabeitia E; Lasheras B; Del Rio J
Brain Res; 1997 May; 757(1):17-23. PubMed ID: 9200494
[TBL] [Abstract][Full Text] [Related]
7. Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans.
Sharpley AL; Solomon RA; Fernando AI; da Roza Davis JM; Cowen PJ
Psychopharmacology (Berl); 1990; 101(4):568-9. PubMed ID: 2117764
[TBL] [Abstract][Full Text] [Related]
8. Evidence for presynaptic location of inhibitory 5-HT1D beta-like autoreceptors in the guinea-pig brain cortex.
Bühlen M; Fink K; Böing C; Göthert M
Naunyn Schmiedebergs Arch Pharmacol; 1996 Feb; 353(3):281-9. PubMed ID: 8692282
[TBL] [Abstract][Full Text] [Related]
9. [Effect of 5HT2 receptor blockade on the startle reflex and its prepulse inhibition in mice and rats of various strains].
Popova NK; Barykina NN; Alekhina TA; Naumenko KS; Kulikov AV
Ross Fiziol Zh Im I M Sechenova; 1999 Jun; 85(6):857-64. PubMed ID: 10512006
[TBL] [Abstract][Full Text] [Related]
10. Ritanserin, a serotonin-2 receptor antagonist, improves ultradian sleep rhythmicity in young poor sleepers.
Viola AU; Brandenberger G; Toussaint M; Bouhours P; Paul Macher J; Luthringer R
Clin Neurophysiol; 2002 Mar; 113(3):429-34. PubMed ID: 11897543
[TBL] [Abstract][Full Text] [Related]
11. Peripherally administered serotonin induces hyperglucagonemia in mice.
Yamada J; Sugimoto Y; Kimura I; Watanabe Y; Takeuchi N; Horisaka K
Life Sci; 1993; 52(23):1845-9. PubMed ID: 8502121
[TBL] [Abstract][Full Text] [Related]
12. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
13. Evidence that m-chlorophenylpiperazine-induced hyperthermia in rats is mediated by stimulation of 5-HT2C receptors.
Mazzola-Pomietto P; Aulakh CS; Wozniak KM; Murphy DL
Psychopharmacology (Berl); 1996 Feb; 123(4):333-9. PubMed ID: 8867872
[TBL] [Abstract][Full Text] [Related]
14. The role of the 5-HT2A and 5-HT2C receptors in the stimulus effects of m-chlorophenylpiperazine.
Fiorella D; Rabin RA; Winter JC
Psychopharmacology (Berl); 1995 May; 119(2):222-30. PubMed ID: 7659770
[TBL] [Abstract][Full Text] [Related]
15. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
Smith RL; Barrett RJ; Sanders-Bush E
J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
[TBL] [Abstract][Full Text] [Related]
16. Differential involvement of serotonin 2A/C and thromboxane A2/prostanoid receptors in high- vs. low-shear rate arterial thrombosis in rabbits.
Valentin JP; Vieu S; Bertolino F; Fauré P; John GW
J Pharmacol Exp Ther; 1997 Feb; 280(2):761-9. PubMed ID: 9023289
[TBL] [Abstract][Full Text] [Related]
17. Analysis of the 5-HT2 receptor ligands dimethoxy-4-indophenyl-2-aminopropane and ketanserin in ethanol discriminations.
Szeliga KT; Grant KA
Alcohol Clin Exp Res; 1998 May; 22(3):646-51. PubMed ID: 9622445
[TBL] [Abstract][Full Text] [Related]
18. Effect of selective 5-HT1A agonists and 5-HT2 antagonists on inherited catalepsy in rats.
Kulikov AV; Kolpakov VG; Maslova GB; Kozintsev I; Popova NK
Psychopharmacology (Berl); 1994 Feb; 114(1):172-4. PubMed ID: 7846200
[TBL] [Abstract][Full Text] [Related]
19. Functional subsensitivity of 5-HT2A and 5-HT2C receptors mediating hyperthermia following acute and chronic treatment with 5-HT2A/2C receptor antagonists.
Mazzola-Pomietto P; Aulakh CS; Tolliver T; Murphy DL
Psychopharmacology (Berl); 1997 Mar; 130(2):144-51. PubMed ID: 9106912
[TBL] [Abstract][Full Text] [Related]
20. Ketanserin and ritanserin discriminate between recombinant human 5-HT1D alpha and 5-HT1D beta receptor subtypes.
Zgombick JM; Schechter LE; Kucharewicz SA; Weinshank RL; Branchek TA
Eur J Pharmacol; 1995 Sep; 291(1):9-15. PubMed ID: 8549648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
